Product Data Sheet

BMS 695735

Catalog No. A34722

main product photo
BMS 695735 is a potent inhibitor of the insulin-like growth factor 1 receptor (IGF-1R), exhibiting an IC50 of 0.034 μM. This compound demonstrates significant anti-tumor activity, making it a valuable tool for cancer research. It is suitable for studies investigating IGF-1R's role in tumorigenesis and for assessing potential therapeutic interventions targeting this receptor.
Chemical Information
Catalog NumA34722
M. Wt512.02
FormulaC26H31ClFN7O
Purity>98%
Storageat -20 °C 3 years (powder form); at -20 °C 6 months (Solution base)
CAS No.1054315-48-8
Synonyms
SMILESO=C1C(C2=NC3=C(C)C=C(C4CCN(CCCF)CC4)C=C3N2)=C(NCCN5N=CC(Cl)=C5)C=CN1
Biological Activity
DescriptionBMS 695735 is a potent inhibitor of the insulin-like growth factor 1 receptor (IGF-1R), exhibiting an IC50 of 0.034 μM. This compound demonstrates significant anti-tumor activity, making it a valuable tool for cancer research. It is suitable for studies investigating IGF-1R's role in tumorigenesis and for assessing potential therapeutic interventions targeting this receptor.
RETURN POLICY
Adooq’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
SHIPPING AND STORAGE
Adooq products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Adooq Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Adooq products are stable under the recommended conditions.